The risk for type B aortic dissection in Marfan syndrome

Journal of the American College of Cardiology

Volumn 65, Issue 3, 2015, Pages 246-254

  Den Hartog, Alexander W ^a,b   Franken, Romy ^a,b   Zwinderman, Aeilko H ^a,b   Timmermans, Janneke ^c   Scholte, Arthur J ^d   Van Den Berg, Maarten P ^e   De Waard, Vivian ^a,e   Pals, Gerard ^f   Mulder, Barbara J M ^a,b   Groenink, Maarten ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

aortic diameter; aortic dissection; aortic distensibility; aortic root replacement; distal aorta; losartan; Marfan syndrome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AORTA DISSECTION; AORTA RECONSTRUCTION; AORTA SURGERY; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DESCENDING AORTA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; SURVIVAL RATE; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; CLASSIFICATION; COMPLICATION; LESIONS AND DEFECTS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RISK ASSESSMENT; SURGERY; THORACIC AORTA; THREE DIMENSIONAL IMAGING;

ADULT; ANEURYSM, DISSECTING; ANGIOTENSIN RECEPTOR ANTAGONISTS; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; DILATATION, PATHOLOGIC; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING, CINE; MALE; MARFAN SYNDROME; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84921354453     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.050     Document Type: Article

References (26)

1. D.I. Silverman, K.J. Burton, and J. Gray Life expectancy in the Marfan syndrome Am J Cardiol 75 1995 157 160
2. P. Engelfriet, E. Boersma, and E. Oechslin The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease Eur Heart J 26 2005 2325 2333
3. M. Groenink, T.A. Lohuis, and J.G. Tijssen Survival and complication free survival in Marfan's syndrome: implications of current guidelines Heart 82 1999 499 504
4. Authors/Task Force Members R. Erbel, V. Aboyans, and C. Boileau 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC) Eur Heart J 35 2014 2873 2926
5. P.M. Engelfriet, E. Boersma, J.G.P. Tijssen, B.J. Bouma, and B.J.M. Mulder Beyond the root: dilatation of the distal aorta in Marfan's syndrome Heart 92 2006 1238 1243
6. B.L. Loeys, H.C. Dietz, and A.C. Braverman The revised Ghent nosology for the Marfan syndrome J Med Genet 47 2010 476 485
7. M.E. Debakey, W.S. Henly, D.A. Cooley, G.C. Morris, E.S. Crawford, and A.C. Beall Surgical management of dissecting aneurysms of the aorta J Thorac Cardiovasc Surg 49 1965 130 149
8. P.O. Daily, H.W. Trueblood, E.B. Stinson, R.D. Wuerflein, and N.E. Shumway Management of acute aortic dissections Ann Thorac Surg 10 1970 237 247
9. A.W. den Hartog, R. Franken, and P. de Witte Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillance Radiology 269 2013 370 377
10. A. Hager, H. Kaemmerer, and U. Rapp-Bernhardt Diameters of the thoracic aorta throughout life as measured with helical computed tomography J Thorac Cardiovasc Surg 123 2002 1060 1066
11. M. Groenink, A. de Roos, B.J. Mulder, J.A. Spaan, and E.E. van der Wall Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome Am J Cardiol 82 1998 203 208
12. M.J. Pencina, and R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 2004 2109 2123
13. A. Wolak, H. Gransar, and L.E.J. Thomson Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area J Am Coll Cardiol Img 1 2008 200 209
14. T. Carrel, L. Beyeler, and A. Schnyder Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery Eur J Cardiothorac Surg 25 2004 671 675
15. B.J.M. Mulder The distal aorta in the Marfan syndrome Neth Heart J 16 2008 382 386
16. R. Finkbohner, D. Johnston, E.S. Crawford, J. Coselli, and D.M. Milewicz Marfan syndrome. Long-term survival and complications after aortic aneurysm repair Circulation 91 1995 728 733
17. G. Mommertz, F. Sigala, and S. Langer Thoracoabdominal aortic aneurysm repair in patients with Marfan syndrome Eur J Vasc Endovasc Surg 35 2008 181 186
18. H.E. Achneck, J.A. Rizzo, M. Tranquilli, and J.A. Elefteriades Safety of thoracic aortic surgery in the present era Ann Thorac Surg 84 2007 1180 1185
19. M. Groenink, A.W. den Hartog, and R. Franken Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial Eur Heart J 34 2013 3491 3500
20. R.V. Lacro, H.C. Dietz, and L.A. Sleeper Atenolol versus losartan in children and young adults with Marfan's syndrome N Engl J Med 371 2014 2061 2071
21. D. Detaint, P. Aegerter, and F. Tubach Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome Arch Cardiovasc Dis 103 2010 317 325
22. A. Forteza, A. Evangelista, and V. Sánchez Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome Rev Esp Cardiol 64 2011 492 498
23. J.P. Habashi, J.J. Doyle, and T.M. Holm Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism Science 332 2011 361 365
24. M.J. Sweeting, S.G. Thompson, L.C. Brown, R.M. Greenhalgh, and J.T. Powell Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms J Vasc Surg 52 2010 1 4
25. R.E. Dinsmore, R.R. Liberthson, and G.L. Wismer Magnetic resonance imaging of thoracic aortic aneurysms: comparison with other imaging methods AJR Am J Roentgenol 146 1986 309 314
26. L.J. Meijboom, M. Groenink, E.E. van der Wall, H. Romkes, J. Stoker, and B.J. Mulder Aortic root asymmetry in Marfan patients; evaluation by magnetic resonance imaging and comparison with standard echocardiography Int J Card Imaging 16 2000 161 168